@andrewcaravello@Clurin5841@DCVaxDefender Thanks Doc! But I'm sorry to say I'm currently tone-deaf to anything from them that's not related to MHRA MAA decision.
Happy 4th!!
@Michael48826289 Unfortunately, not many believe it would come to anything. Seen this movie before. Just hope this absolute frustrating wait soon comes to an end.
@Kenneth83risom@Dave46217976 Now This!!! And then its compassionate use for yrs authorized by MHRA with proven efficacy and safety. So what is it regarding the pending MHRA MAA decision hold-up that all Longs are missing?
@jaygreco194737@andrewcaravello I totally agree with this question. I think Linda's too cautious as she's bound by mhra regulations...and regulations can be murky...doesn't want to take any chance in appearing to pump a vaccine that's under review. Maybe different for Anktiva. There's a valid reason she's not.
@SouthernDrive21 MHRA has authorized specials, compassionate application of dcvax, it has and continues to show benefits with almost nonexistent side effects, relatively speaking. So why then almost 900days post validation? It's either the novelty and complexity of dcvax or something's very off!
$NWBO
“My 18-year-old daughter Braelyn and I are currently in London so she can receive DCVax-L, an immunotherapy developed in the United States.
Despite being pioneered by an American neurosurgeon and showing encouraging long-term survival data, we could not access it in the United States.
Instead, we’re paying hundreds of thousands of dollars, traveling across the Atlantic, and spending weeks away from home to pursue a treatment that originated in our own country….”
- @HollensbeAmanda
Families should not have to go overseas to access American innovation.
Northwest Biotherapeutics should not have to fight a multi year court battle to stop market manipulators from trying to destroy $NWBO
Why are regulators allowed to look the other way?
It’s beyond time to Demand Trade Settlement @pulte@DOJFraudDiv@JDVance
@amanpour@Martina https://t.co/PvIy8OT1W6
@amanpour & @Martina
Pls see a very promising cancer vaccine now under UK mhra review for approval for use in the UK, but developed by a small US company in nbwo.
$NWBO
“My 18-year-old daughter Braelyn and I are currently in London so she can receive DCVax-L, an immunotherapy developed in the United States.
Despite being pioneered by an American neurosurgeon and showing encouraging long-term survival data, we could not access it in the United States.
Instead, we’re paying hundreds of thousands of dollars, traveling across the Atlantic, and spending weeks away from home to pursue a treatment that originated in our own country….”
- @HollensbeAmanda
Families should not have to go overseas to access American innovation.
Northwest Biotherapeutics should not have to fight a multi year court battle to stop market manipulators from trying to destroy $NWBO
Why are regulators allowed to look the other way?
It’s beyond time to Demand Trade Settlement @pulte@DOJFraudDiv@JDVance
@rjmsoflo@ElvirPons One must also admit mhra is made up of very smart scientists. Given all what you've said in terms of a delay that's beyond anything ever seen which far exceeds the norm, isn't it time as investors we start asking what is it abt dcvax or otherwise causing this unprecedented delay?
We’re living the Right-to-Try problem in real time.
My 18-year-old daughter Braelyn and I are currently in London so she can receive DCVax-L, an immunotherapy developed in the United States. Despite being pioneered by an American neurosurgeon and showing encouraging long-term survival data, we could not access it in the United States.
Instead, we’re paying hundreds of thousands of dollars, traveling across the Atlantic, and spending weeks away from home to pursue a treatment that originated in our own country.
Patients facing terminal illnesses deserve meaningful access to promising therapies—not just in theory, but in practice.
@RichFairgrieve Great find, thank you!!
Would really have been nice and a huge boost to nwbo and it's SP had this come out after MAA approval. I guess mgmt didnt anticipate it taking as long as it did?? Just a thought...
@alphavestcap If dcvax MAA approval PR is close, I'd wait to 1st release the MHRA MAA approval, and then soon after that submit the said IND and follow with another PR which would combine to significantly boost confidence in nwbo and the SP bounce from MAA submission.
@SouthernDrive21 Can u tell us how the judges decision affects nwbo either way he elects? I'm sure these writings are foreign language to most of us lol.
Appreciate all the good work.